FIRST: Glenmark launches Whatsapp based chatbot Hello skin for fungal infection patients in India

This platform is patient friendly and will be available in 6 different regional languages including Hindi and English, enabling better patient compliance to the technology.;

Published On 2022-05-25 07:21 GMT | Update On 2022-05-25 07:21 GMT

Mumbai: Glenmark Pharmaceuticals Ltd., has developed an digital patient education tool, "Hello Skin" in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists), to help patients suffering from Dermatophytosis (Ring Worm or Tinea) in India, to adhere to the recommended treatment duration.

"Hello skin" is the first Whatsapp based chatbot, which helps patients in not only improving adherence to topical/systemic recommended therapy with daily pill reminders, but also in creating disease awareness and provides skincare tips to patients suffering from Ring Worm. This platform is patient friendly and will be available in 6 different regional languages including Hindi and English, enabling better patient compliance to the technology.

On this development, Alok Malik, Group Vice President and Head, India Formulations, Glenmark Pharmaceuticals Ltd. Said, "Digital patient inclusion for better disease management is the way forward in healthcare. 'Hello Skin' is an initiative in this direction and will help improve disease education and patient adherence to fungal therapy. IADVL's collaboration with Glenmark for developing this innovative solution, further adds to its credibility amongst dermatologists and patients."

Supporting the novel initiative, Dr. Rashmi Sarkar, President, IADVL said, "Fostering treatment adherence is a priority objective especially in management of fungal infections. "'Hello Skin' will be one such digital initiative to partner patients in their treatment journey to improve clinical outcomes in patient suffering from fungal infections.

The recent prevalence of Dermatophytosis (often called Ring Worm) in India has reached up to 78.4%.

Additionally, it has become one of the most difficult infections to treat in recent times with patients reporting feelings of depression and isolation due to the social taboo associated with it.

Dr Lalit Gupta, Chairperson, IADVL Academy said "Creating awareness about Dermatophytosis, often referred to as Ring Worm, is critical since this fungal infection can spread easily from one person to another, and it is easy for the patients to fall into a state of despair. It requires patients to adhere to the recommended therapy in a timely manner, for successful treatment. I think this chatbot is a new way to help patients in times where digitalization has become an integral part of our lives"

Dermatologists say, they are perplexed with the recurring nature of the disease. Although there are multiple oral and topical treatments options available, dermatologists are stressing on the importance of patients' adherence to treatment and avoidance of steroid abuse are essential to successful treatment of the disease.

However, despite these warnings, patients more often discontinue the therapy upon relief from itching. Glenmark has introduced this platform to the dermatologists across the country, who can recommend it to their patients for effectively dealing with Ring Worm. The "Hello skin" chatbot will support patient adherence throughout the recommended duration of the therapy.

Fungal infection is a highly contagious infection of the skin or scalp and characterized by ring-like rashes anywhere on the body or the face. It spreads through direct contact with infected skin or fungal spores. The spores can live on fabrics, including clothing, couch cushions, bedding, and other porous surfaces. They also thrive in damp environments, such as public showers and locker rooms.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

FIRST: Glenmark launches Whatsapp based chatbot Hello skin for fungal infection patients in India

This platform is patient friendly and will be available in 6 different regional languages including Hindi and English, enabling better patient compliance to the technology.;

Similar News

Aster DM Healthcare, India appoints Sudeep Dey as CIO, CISO

No Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in India

Zydus Wellness incorporates wholly owned subsidiary in UK

Teva Pharma announces USFDA filing acceptance for Ajovy in Pediatric Episodic Migraine prevention

Sanofi completes acquisition of Vigil Neuroscience

NPPA Caps Prices of Ipratropium, Sodium Nitroprusside, Two Other Essential Drugs

Akum Pharma Asked to Submit Safety Data for Alzheimer's Drug Combo In Elderly Indian Patients

Aurobindo Pharma net profit drops 10 percent to Rs 824 crore in Q1